Trials / Sponsors / Pell Bio-Med Technology Co., Ltd.
Pell Bio-Med Technology Co., Ltd.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy Diffuse Large B Cell Lymphoma, Large B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma | — | 2022-12-29 |
| Recruiting | Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma | Phase 1 / Phase 2 | 2022-05-31 |